{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:10:44Z","timestamp":1790104244600,"version":"4.0.1"},"reference-count":150,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1097\/dad.0b013e31828a2ec5","type":"journal-article","created":{"date-parts":[[2014,5,7]],"date-time":"2014-05-07T07:12:18Z","timestamp":1399446738000},"page":"363-379","source":"Crossref","is-referenced-by-count":150,"title":["Cutaneous Malignant Melanoma"],"prefix":"10.1097","volume":"36","author":[{"given":"Ossama","family":"Abbas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel D.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jag","family":"Bhawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210202","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00001622-199403000-00011","article-title":"Etiology, epidemiology, risk factors, and public health issues of melanoma.","volume":"6","author":"Elwood","year":"1994","journal-title":"Curr Opin Oncol"},{"key":"R2-1-20210202","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/978-0-387-77574-6_8","article-title":"Epidemiology of melanoma and nonmelanoma skin cancerthe role of sunlight.","volume":"624","author":"Leiter","year":"2008","journal-title":"Adv Exp Med Biol"},{"key":"R3-1-20210202","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1038\/modpathol.3800516","article-title":"Unusual variants of malignant melanoma.","volume":"19","author":"Magro","year":"2006","journal-title":"Mod Pathol"},{"key":"R4-1-20210202","first-page":"47","article-title":"The histopathology of cutaneous malignant melanoma.","volume":"10","author":"Barnhill","year":"1993","journal-title":"Semin Diagn Pathol"},{"key":"R5-1-20210202","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00000372-200206000-00016","article-title":"Immunohistochemical markers of melanocytic lesions: a review of their diagnostic usefulness.","volume":"24","author":"Mangini","year":"2002","journal-title":"Am J Dermatopathol"},{"key":"R6-1-20210202","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-0560.2007.00891.x","article-title":". Immunohistochemical characteristics of melanoma.","volume":"35","author":"Ohsie","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R7-1-20210202","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jnci\/djp038","article-title":"Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.","volume":"101","author":"Gould Rothberg","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"R8-1-20210202","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jaad.2004.08.034","article-title":". Molecular diagnostics in melanoma.","volume":"52","author":"Carlson","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R9-1-20210202","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1200\/JCO.2001.19.16.3622","article-title":". Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.","volume":"19","author":"Balch","year":"2001","journal-title":"J Clin Oncol"},{"key":"R10-1-20210202","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9","article-title":"The Ki-67 protein: from the known and the unknown.","volume":"182","author":"Scholzen","year":"2000","journal-title":"J Cell Physiol"},{"key":"R11-1-20210202","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/00000372-200012000-00002","article-title":". A zonal comparison of MIB1-Ki67 immunoreactivity in benign and malignant melanocytic lesions.","volume":"22","author":"Li","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"R12-1-20210202","first-page":"917","article-title":". Immunohistochemical markers for distinguishing Spitz nevi from malignant melanomas.","volume":"10","author":"Kanter-Lewensohn","year":"1997","journal-title":"Mod Pathol"},{"key":"R13-1-20210202","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/01.MP.0000072747.08404.38","article-title":". Ki-67 and p53 expression in minimal deviation melanomas as compared with other nevomelanocytic lesions.","volume":"16","author":"Chorny","year":"2003","journal-title":"Mod Pathol"},{"key":"R14-1-20210202","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1600-0560.2007.00912.x","article-title":". G1 cell cycle regulators in congenital melanocytic nevi. Comparison with acquired nevi and melanomas.","volume":"35","author":"Stefanski","year":"2008","journal-title":"J Cutan Pathol"},{"key":"R15-1-20210202","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2133.2001.04335.x","article-title":". Prognostic immunohistochemical markers of primary human melanomas.","volume":"145","author":"Ostmeier","year":"2001","journal-title":"Br J Dermatol"},{"key":"R16-1-20210202","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00000372-199802000-00003","article-title":". Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors.","volume":"20","author":"Sparrow","year":"1998","journal-title":"Am J Dermatopathol"},{"key":"R17-1-20210202","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1053\/hupa.2001.29658","article-title":". High proliferative activity may predict early metastasis of thin melanomas.","volume":"32","author":"Frahm","year":"2001","journal-title":"Hum Pathol"},{"key":"R18-1-20210202","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/cncr.10685","article-title":". Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma.","volume":"95","author":"Hazan","year":"2002","journal-title":"Cancer"},{"key":"R19-1-20210202","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1097\/DAD.0b013e3181cf7cc1","article-title":". Use of anti-phosphohistone H3 immunohistochemistry to determine mitotic rate in thin melanoma.","volume":"32","author":"Casper","year":"2010","journal-title":"Am J Dermatopathol"},{"key":"R20-1-20210202","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1097\/01.pas.0000141389.06925.d5","article-title":". The mitosis-specific antibody anti-phosphohistone-H3 (PHH3) facilitates rapid reliable grading of meningiomas according to WHO 2000 criteria.","volume":"28","author":"Ribalta","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R21-1-20210202","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/01.pas.0000202048.28203.25","article-title":". Assessment and prognostic significance of mitotic index using the mitosis marker phosphohistone H3 in low and intermediate-grade infiltrating astrocytomas.","volume":"30","author":"Colman","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R22-1-20210202","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1600-0560.2011.01858.x","article-title":". Immunohistochemical dual staining as an adjunct in assessment of mitotic activity in melanoma.","volume":"39","author":"Ikenberg","year":"2012","journal-title":"J Cutan Pathol"},{"issue":"3","key":"R23-1-20210202","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/modpathol.2012.188","article-title":"Proliferation indices of phosphohistone H3 and Ki67: strong prognostic markers in a consecutive cohort with stage III melanoma.","volume":"26","author":"Nielsen","year":"2013","journal-title":"Mod Pathol"},{"key":"R24-1-20210202","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/(SICI)1097-0215(19970620)74:3<255::AID-IJC4>3.0.CO;2-Y","article-title":". Loss of expression of the p16 INK4CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage.","volume":"74","author":"Talve","year":"1997","journal-title":"Int J Cancer"},{"key":"R25-1-20210202","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-0560.2008.01154.x","article-title":"p16 Expression differentiates between desmoplastic Spitz nevus and desmoplastic melanoma.","volume":"36","author":"Hilliard","year":"2009","journal-title":"J Cutan Pathol"},{"key":"R26-1-20210202","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jaad.2010.07.031","article-title":". p16 Expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.","volume":"65","author":"Al Dhaybi","year":"2011","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"R27-1-20210202","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/cup.12014","article-title":"Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma.","volume":"39","author":"Mason","year":"2012","journal-title":"J Cutan Pathol"},{"key":"R28-1-20210202","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0002-9440(10)63110-0","article-title":". Progression in cutaneous malignant melanoma is associated with distinct expression profiles.","volume":"164","author":"Alonso","year":"2004","journal-title":"Am J Pathol"},{"key":"R29-1-20210202","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1309\/YT58WWMTA6YR1PRV","article-title":". Expression of activated Akt and PTEN in malignant melanomas: relationship with clinical outcome.","volume":"124","author":"Slipicevic","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R30-1-20210202","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1309\/CHFHEYAT44WWP7J3","article-title":"Expression of activated TrkA protein in melanocytic tumors: relationship to cell proliferation and clinical outcome.","volume":"122","author":"Florenes","year":"2004","journal-title":"Am J Clin Pathol"},{"key":"R31-1-20210202","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/modpathol.3800750","article-title":". Mcl-1, Bcl-XL and Stat3 expression are associated with progression of melanoma whereas Bcl-2, AP-2 and MITF levels decrease during progression of melanoma.","volume":"20","author":"Zhuang","year":"2007","journal-title":"Mod Pathol"},{"key":"R32-1-20210202","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.cmr.0000232290.61042.ee","article-title":"Cyclin dependent kinase 2 expression in human melanomas and benign melanocytic skin lesions.","volume":"16","author":"Kuzbicki","year":"2006","journal-title":"Melanoma Res"},{"key":"R33-1-20210202","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0046-8177(98)90418-X","article-title":". Mitotic cyclins and cyclin dependent kinases in melanocytic lesions.","volume":"29","author":"Tran","year":"1998","journal-title":"Hum Pathol"},{"key":"R34-1-20210202","first-page":"3697","article-title":". Differential expression of growth arrest, DNA damage genes and tumour suppressor gene p53 in naevi and malignant melanomas.","volume":"17","author":"Korabiowska","year":"1997","journal-title":"Anticancer Res"},{"key":"R35-1-20210202","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/jnci\/94.23.1803","article-title":". HDM2 protein overexpression and prognosis in primary malignant melanoma.","volume":"94","author":"Polsky","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"R36-1-20210202","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/1066896909336177","article-title":". Reduced p16 and increased cyclin D1 and pRb expression are correlated with progression in cutaneous melanocytic tumors.","volume":"17","author":"Karim","year":"2009","journal-title":"Int J Surg Pathol"},{"key":"R37-1-20210202","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.0303-6987.2004.00243.x","article-title":". Skp2 and p27kip1 expression in melanocytic nevi and melanoma: an inverse relationship.","volume":"31","author":"Li","year":"2004","journal-title":"J Cutan Pathol"},{"key":"R38-1-20210202","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/j.1365-2133.2004.06260.x","article-title":"Melanoma or not Cancer testis antigens may help.","volume":"151","author":"Luftl","year":"2004","journal-title":"Br J Dermatol"},{"key":"R39-1-20210202","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1046\/j.1365-2133.1998.02171.x","article-title":"Expression of CD26dipeptidyl peptidase IV in benign and malignant pigment-cell lesions of the skin.","volume":"138","author":"van den Oord","year":"1998","journal-title":"Br J Dermatol"},{"key":"R40-1-20210202","first-page":"1953","article-title":". CD40 is a prognostic marker in primary cutaneous malignant melanoma.","volume":"149","author":"van den Oord","year":"1996","journal-title":"Am J Pathol"},{"key":"R41-1-20210202","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1046\/j.0022-202x.2001.01418.x","article-title":". Selective expression of FLIP in malignant melanocytic skin lesions.","volume":"117","author":"Bullani","year":"2001","journal-title":"J Invest Dermatol"},{"key":"R42-1-20210202","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00000372-199310000-00005","article-title":"Immunohistochemical study of Spitz nevi and malignant melanoma with use of antibody to proliferating cell nuclear antigen.","volume":"15","author":"Niemann","year":"1993","journal-title":"Am J Dermatopathol"},{"key":"R43-1-20210202","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/01.MP.0000071128.67149.FD","article-title":"S100A6 protein expression is different in Spitz nevi and melanomas.","volume":"16","author":"Ribe","year":"2003","journal-title":"Mod Pathol"},{"key":"R44-1-20210202","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0002-9440(10)63536-5","article-title":". Classifying melanocytic tumors based on DNA copy number changes.","volume":"163","author":"Bastian","year":"2003","journal-title":"Am J Pathol"},{"key":"R45-1-20210202","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1529-8019.2005.00055.x","article-title":"Distinguishing melanocytic nevi from melanoma by DNA copy number changes: comparative genomic hybridization as a research and diagnostic tool.","volume":"19","author":"Bauer","year":"2006","journal-title":"Dermatol Ther"},{"key":"R46-1-20210202","first-page":"589","article-title":". Allelotypes of primary cutaneous melanoma and benign melanocytic nevi.","volume":"56","author":"Healy","year":"1996","journal-title":"Cancer Res"},{"key":"R47-1-20210202","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1158\/1078-0432.CCR-06-2383","article-title":". Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma.","volume":"13","author":"Onken","year":"2007","journal-title":"Clin Cancer Res"},{"key":"R48-1-20210202","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cancergencyto.2006.05.004","article-title":". Correlation of comparative genomic hybridization results of 100 archival uveal melanomas with patient survival.","volume":"170","author":"White","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"R50-1-20210202","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1093\/nar\/gnf056","article-title":". Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.","volume":"30","author":"Schouten","year":"2002","journal-title":"Nucleic Acids Res"},{"key":"R51-1-20210202","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/01.pas.0000146701.98954.47","article-title":". Multiplex ligation-dependent probe amplification for the detection of chromosomal gains and losses in formalin-fixed tissue.","volume":"14","author":"van Dijk","year":"2005","journal-title":"Diagn Mol Pathol"},{"key":"R52-1-20210202","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jdermsci.2005.06.009","article-title":". Genome profiling of melanocytic tumors using multiplex ligation dependent probe amplification (MLPA): its usefulness as an adjunctive diagnostic tool for melanocytic tumors.","volume":"40","author":"Takata","year":"2005","journal-title":"J Dermatol Sci"},{"key":"R53-1-20210202","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1097\/PAS.0b013e3181a1ef36","article-title":". Fluorescence in situ hybridization (FISH) as an ancillary diagnostic tool in the diagnosis of melanoma.","volume":"33","author":"Gerami","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R54-1-20210202","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1097\/PAS.0b013e31822678d2","article-title":". Melanocytic nevi with an atypical epithelioid cell component: clinical, histopathologic, and fluorescence in situ hybridization findings.","volume":"35","author":"Pouryazdanparast","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R55-1-20210202","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0560.2010.01666.x","article-title":". Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi.","volume":"38","author":"Gerami","year":"2011","journal-title":"J Cutan Pathol"},{"key":"R56-1-20210202","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1097\/PAS.0b013e3181a92cbc","article-title":". Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization.","volume":"33","author":"Pouryazdanparast","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"R57-1-20210202","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/PAS.0b013e3181c805c4","article-title":". Use of fluorescence in situ hybridization (FISH) to distinguish intranodal nevus from metastatic melanoma.","volume":"34","author":"Dalton","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R58-1-20210202","first-page":"335","article-title":". Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus-like melanoma.","volume":"38","author":"Gammon","year":"2011","journal-title":"J Cutan Pathol"},{"key":"R59-1-20210202","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/PAS.0b013e31822d5ff8","article-title":". Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.","volume":"36","author":"Gammon","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R60-1-20210202","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/modpathol.2009.177","article-title":". Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up.","volume":"23","author":"Gaiser","year":"2010","journal-title":"Mod Pathol"},{"key":"R61-1-20210202","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/PAS.0b013e31824b1efd","article-title":". A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms.","volume":"36","author":"Gerami","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R62-1-20210202","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jdermsci.2006.05.002","article-title":"Genetic alterations in melanocytic tumors.","volume":"43","author":"Takata","year":"2006","journal-title":"J Dermatol Sci"},{"key":"R63-1-20210202","first-page":"4","article-title":". Understanding spitzoid tumours: new insights from molecular pathology.","volume":"158","author":"Da Forno","year":"2008","journal-title":"Br J Dermatol"},{"key":"R64-1-20210202","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0002-9440(10)64609-3","article-title":"Mutations and copy number increase of HRAS in Spitz nevi with distinctive histopathological features.","volume":"157","author":"Bastian","year":"2000","journal-title":"Am J Pathol"},{"key":"R65-1-20210202","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2133.2009.09181.x","article-title":". BRAF, NRAS and HRAS mutations in spitzoid tumours and their possible pathogenetic significance.","volume":"161","author":"Da Forno","year":"2009","journal-title":"Br J Dermatol"},{"key":"R66-1-20210202","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/modpathol.3800653","article-title":". BRAF and NRAS mutations in spitzoid melanocytic lesions.","volume":"19","author":"Fullen","year":"2006","journal-title":"Mod Pathol"},{"key":"R67-1-20210202","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1600-0560.2009.01433.x","article-title":". Oncogenic BRAF and the tumor suppressor IGFBP7 in the genesis of atypical spitzoid nevomelanocytic proliferations.","volume":"37","author":"Emley","year":"2010","journal-title":"J Cutan Pathol"},{"key":"R68-1-20210202","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1002\/cncr.20680","article-title":". Genetic similarities between Spitz nevus and Spitzoid melanoma in children.","volume":"101","author":"Gill","year":"2004","journal-title":"Cancer"},{"key":"R69-1-20210202","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.0303-6987.2003.00179.x","article-title":". The T1796A mutation of the BRAF gene is absent in Spitz nevi.","volume":"31","author":"Palmedo","year":"2004","journal-title":"J Cutan Pathol"},{"key":"R70-1-20210202","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/cncr.21686","article-title":". Are all melanomas the same Spitzoid melanoma is a distinct subtype of melanoma.","volume":"106","author":"Lee","year":"2006","journal-title":"Cancer"},{"key":"R71-1-20210202","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1365-2133.2007.07924.x","article-title":". Genetic and epigenetic alterations in the differential diagnosis of malignant melanoma and spitzoid lesion.","volume":"156","author":"Takata","year":"2007","journal-title":"Br J Dermatol"},{"key":"R72-1-20210202","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/01.pas.0000157749.18591.9e","article-title":"Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.","volume":"29","author":"van Dijk","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R73-1-20210202","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1755-148X.2008.00534.x","article-title":"Epigenetic marks in melanoma.","volume":"22","author":"Richards","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"R75-1-20210202","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1600-0749.2007.00367.x","article-title":"Epigenetic events in malignant melanoma.","volume":"20","author":"Rothhammer","year":"2007","journal-title":"Pigment Cell Res"},{"key":"R76-1-20210202","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/107327480901600302","article-title":". Epigenetics in human melanoma.","volume":"16","author":"Howell","year":"2009","journal-title":"Cancer Control"},{"key":"R77-1-20210202","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/CMR.0b013e328338a35a","article-title":". Aberrant DNA methylation in malignant melanoma.","volume":"20","author":"Schinke","year":"2010","journal-title":"Melanoma Res"},{"key":"R78-1-20210202","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1479-5876-8-56","article-title":". Epigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategies.","volume":"8","author":"Sigalotti","year":"2010","journal-title":"J Transl Med"},{"key":"R79-1-20210202","first-page":"2042","article-title":"Gene silencing in cancer in association with promoter hypermethylation, N Engl J Med.","volume":"349","author":"Herman","year":"2003","journal-title":""},{"key":"R80-1-20210202","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1093\/nar\/gni127","article-title":". Methylation-specific MLPA (MS-MLPA): simultaneous detection of CpG methylation and copy number changes of up to 40 sequences.","volume":"33","author":"Nygren","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"R82-1-20210202","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1038\/jid.2008.452","article-title":"miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma.","volume":"129","author":"Mueller","year":"2009","journal-title":"J Invest Dermatol"},{"key":"R83-1-20210202","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1158\/0008-5472.CAN-09-4512","article-title":". Signatures of microRNAs and selected microRNA target genes in human melanoma.","volume":"70","author":"Philippidou","year":"2010","journal-title":"Cancer Res"},{"key":"R84-1-20210202","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.tcb.2008.07.007","article-title":"The let-7 family of microRNAs.","volume":"18","author":"Roush","year":"2008","journal-title":"Trends Cell Biol"},{"key":"R85-1-20210202","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/cr.2008.45","article-title":". MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth.","volume":"18","author":"Schultz","year":"2008","journal-title":"Cell Res"},{"key":"R86-1-20210202","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function.","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"R87-1-20210202","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1158\/1541-7786.MCR-10-0511","article-title":". EZH2-dependent suppression of a cellular senescence phenotype in melanoma cells by inhibition of p21CDKN1A expression.","volume":"9","author":"Fan","year":"2011","journal-title":"Mol Cancer Res"},{"key":"R88-1-20210202","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1158\/1535-7163.425.3.4","article-title":". The histone deacetylase inhibitor suberic bishydroxamate regulates the expression of multiple apoptotic mediators and induces mitochondria-dependent apoptosis of melanoma cells.","volume":"3","author":"Zhang","year":"2004","journal-title":"Mol Cancer Ther"},{"key":"R89-1-20210202","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1073\/pnas.0501564102","article-title":". The gene expression signatures of melanoma progression.","volume":"102","author":"Haqq","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R90-1-20210202","doi-asserted-by":"crossref","first-page":"6268","DOI":"10.1073\/pnas.0901185106","article-title":". A multimarker assay to distinguish malignant melanomas from benign nevi.","volume":"106","author":"Kashani-Sabet","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R91-1-20210202","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1158\/1078-0432.CCR-05-0683","article-title":". Novel genes associated with malignant melanoma but not benign melanocytic lesions.","volume":"11","author":"Talantov","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R92-1-20210202","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":". Final version of 2009 AJCC melanoma staging and classification.","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"key":"R93-1-20210202","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1001\/archdermatol.2009.230","article-title":"A glimpse of future management of melanoma.","volume":"145","author":"Cochran","year":"2009","journal-title":"Arch Dermatol"},{"key":"R94-1-20210202","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.clindermatol.2008.09.007","article-title":"New techniques in dermatopathology that help to diagnose and prognosticate melanoma.","volume":"27","author":"Carlson","year":"2009","journal-title":"Clin Dermatol"},{"key":"R95-1-20210202","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1200\/JCO.2006.08.1463","article-title":". Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.","volume":"25","author":"Gimotty","year":"2007","journal-title":"J Clin Oncol"},{"key":"R96-1-20210202","doi-asserted-by":"crossref","first-page":"11185","DOI":"10.1158\/0008-5472.CAN-05-2300","article-title":". Automated quantitative analysis of activator protein-2alpha subcellular expression in melanoma tissue microarrays correlates with survival prediction.","volume":"65","author":"Berger","year":"2005","journal-title":"Cancer Res"},{"key":"R97-1-20210202","doi-asserted-by":"crossref","first-page":"3584","DOI":"10.1200\/JCO.1998.16.11.3584","article-title":". Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma.","volume":"16","author":"Karjalainen","year":"1998","journal-title":"J Clin Oncol"},{"key":"R98-1-20210202","first-page":"8103","article-title":". Subcellular localization of activating transcription factor 2 in melanoma specimens predicts patient survival.","volume":"63","author":"Berger","year":"2003","journal-title":"Cancer Res"},{"key":"R99-1-20210202","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1200\/JCO.2006.07.3833","article-title":". Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma.","volume":"24","author":"Rangel","year":"2006","journal-title":"J Clin Oncol"},{"key":"R100-1-20210202","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1158\/0008-5472.CAN-06-3481","article-title":". A high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasis.","volume":"67","author":"Alonso","year":"2007","journal-title":"Cancer Res"},{"key":"R101-1-20210202","doi-asserted-by":"crossref","first-page":"8773","DOI":"10.1158\/0008-5472.CAN-04-1387","article-title":". Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma.","volume":"64","author":"Divito","year":"2004","journal-title":"Cancer Res"},{"key":"R102-1-20210202","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1365-2559.2007.02695.x","article-title":". Nuclear survivin is associated with disease recurrence and poor survival in patients with cutaneous malignant melanoma.","volume":"50","author":"Piras","year":"2007","journal-title":"Histopathology"},{"key":"R103-1-20210202","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1200\/JCO.2002.05.033","article-title":". CEACAM1 expression in cutaneous malignant melanoma predicts the development of metastatic disease.","volume":"20","author":"Thies","year":"2002","journal-title":"J Clin Oncol"},{"key":"R104-1-20210202","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1158\/1078-0432.CCR-04-1887","article-title":". Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma.","volume":"11","author":"Scala","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R105-1-20210202","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0002-9440(10)64608-1","article-title":". Reduced level of CD44 and hyaluronan associated with unfavorable prognosis in clinical stage I cutaneous melanoma.","volume":"157","author":"Karjalainen","year":"2000","journal-title":"Am J Pathol"},{"key":"R106-1-20210202","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.PRS.0000148417.86768.C9","article-title":". Development of a tissue array for primary melanoma with long-term follow-up: discovering melanoma cell adhesion molecule as an important prognostic marker.","volume":"115","author":"Pacifico","year":"2005","journal-title":"Plast Reconstr Surg"},{"key":"R107-1-20210202","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bjps.2007.04.010","article-title":". Stratification of patients by melanoma cell adhesion molecule (MCAM) expression on the basis of risk: implications for sentinel lymph node biopsy.","volume":"61","author":"Pearl","year":"2008","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R108-1-20210202","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/S0959-8049(02)00105-3","article-title":". Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma.","volume":"38","author":"Thies","year":"2002","journal-title":"Eur J Cancer"},{"key":"R109-1-20210202","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.humpath.2007.06.021","article-title":"Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma.","volume":"39","author":"Vaisanen","year":"2008","journal-title":"Hum Pathol"},{"key":"R110-1-20210202","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/(SICI)1096-9896(199809)186:1<51::AID-PATH131>3.0.CO;2-P","article-title":". Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma.","volume":"186","author":"Vaisanen","year":"1998","journal-title":"J Pathol"},{"key":"R111-1-20210202","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/cncr.23147","article-title":". Osteopontin as a molecular prognostic marker for melanoma.","volume":"112","author":"Rangel","year":"2008","journal-title":"Cancer"},{"key":"R112-1-20210202","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2559.2004.01976.x","article-title":". Tenascin-C in primary malignant melanoma of the skin.","volume":"45","author":"Ilmonen","year":"2004","journal-title":"Histopathology"},{"key":"R113-1-20210202","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1054\/bjoc.2000.1460","article-title":". High tPA expression in primary melanoma of the limb correlates with good prognosis.","volume":"83","author":"Ferrier","year":"2000","journal-title":"Br J Cancer"},{"key":"R114-1-20210202","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/(SICI)1096-9098(199903)70:3<150::AID-JSO2>3.0.CO;2-Z","article-title":". Prognostic evaluation of cutaneous malignant melanoma: a clinicopathologic and immunohistochemical study.","volume":"70","author":"Niezabitowski","year":"1999","journal-title":"J Surg Oncol"},{"key":"R115-1-20210202","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ijc.21767","article-title":". Tumor iNOS predicts poor survival for stage III melanoma patients.","volume":"119","author":"Ekmekcioglu","year":"2006","journal-title":"Int J Cancer"},{"key":"R116-1-20210202","first-page":"1845","article-title":"Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma.","volume":"6","author":"Straume","year":"2000","journal-title":"Clin Cancer Res"},{"key":"R117-1-20210202","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1158\/1055-9965.EPI-11-0472","article-title":". Prognostic significance of cytoplasmic p27 expression in human melanoma.","volume":"20","author":"Chen","year":"2011","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"R118-1-20210202","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/path.1007","article-title":". Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.","volume":"195","author":"Florenes","year":"2001","journal-title":"J Pathol"},{"key":"R119-1-20210202","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0002-9440(10)62493-5","article-title":". Microtubule associated protein 2, a marker of neuronal differentiation, induces mitotic defects, inhibits growth of melanoma cells, and predicts metastatic potential of cutaneous melanoma.","volume":"166","author":"Soltani","year":"2005","journal-title":"Am J Pathol"},{"key":"R120-1-20210202","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/sj.bjc.6603028","article-title":". Metallothioneinoverexpression as a highly significant prognostic factor in melanoma: a prospective study on 1270 patients.","volume":"94","author":"Weinlich","year":"2006","journal-title":"Br J Cancer"},{"key":"R121-1-20210202","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1468-3083.2006.02051.x","article-title":". Comparison of metallothionein-overexpression with sentinel lymph node biopsy as prognostic factors in melanoma.","volume":"21","author":"Weinlich","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R122-1-20210202","doi-asserted-by":"crossref","first-page":"8048","DOI":"10.1200\/JCO.2005.02.0735","article-title":". Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.","volume":"23","author":"Gimotty","year":"2005","journal-title":"J Clin Oncol"},{"key":"R123-1-20210202","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0002-9440(10)64922-X","article-title":"Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factorfibroblast growth factor receptor-1 and ephrin-A1EphA2 on melanoma progression.","volume":"160","author":"Straume","year":"2002","journal-title":"Am J Pathol"},{"key":"R124-1-20210202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1600-0560.2006.00569.x","article-title":". Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR-1, c-kit) in nevi and melanoma.","volume":"34","author":"Giehl","year":"2007","journal-title":"J Cutan Pathol"},{"key":"R125-1-20210202","doi-asserted-by":"crossref","first-page":"8606","DOI":"10.1158\/1078-0432.CCR-05-0011","article-title":". Importance of P-cadherin, -catenin, and Wnt5afrizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma.","volume":"11","author":"Bachmann","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R126-1-20210202","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1046\/j.1365-2133.2001.04336.x","article-title":". Loss of -catenin expression associated with disease progression in malignant melanoma.","volume":"145","author":"Kageshita","year":"2001","journal-title":"Br J Dermatol"},{"key":"R127-1-20210202","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1038\/onc.2011.162","article-title":". In melanoma, beta-catenin is a suppressor of invasion.","volume":"30","author":"Arozarena","year":"2011","journal-title":"Oncogene"},{"key":"R128-1-20210202","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/cncr.20984","article-title":". Clinicopathologic significance of dysadherin expression in cutaneous malignant melanoma: immunohistochemical analysis of 115 patients.","volume":"103","author":"Nishizawa","year":"2005","journal-title":"Cancer"},{"key":"R129-1-20210202","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1002\/path.1595","article-title":". The developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in cutaneous malignant melanoma.","volume":"203","author":"Thies","year":"2004","journal-title":"J Pathol"},{"key":"R130-1-20210202","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/0012-1606(84)90334-8","article-title":"A cell surface marker for neural crest and placodal cells: further evolution in peripheral and central nervous system.","volume":"103","author":"Vincent","year":"1984","journal-title":"Dev Biol"},{"key":"R131-1-20210202","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/00008390-200310000-00008","article-title":". Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin.","volume":"13","author":"Giatromanolaki","year":"2003","journal-title":"Melanoma Res"},{"key":"R132-1-20210202","first-page":"805","article-title":". GADD153 is an independent prognostic factor in melanoma: immunohistochemical and molecular genetic analysis.","volume":"17","author":"Korabiowska","year":"2002","journal-title":"Histol Histopathol"},{"key":"R133-1-20210202","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/j.1600-0560.2006.00501.x","article-title":". Chromogenic in situ hybridization analysis of melastatin mRNA expression in melanomas from American Joint Committee on Cancer stage I and II patients with recurrent melanoma.","volume":"33","author":"Hammock","year":"2006","journal-title":"J Cutan Pathol"},{"key":"R134-1-20210202","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1200\/JCO.2001.19.2.568","article-title":". Melastatin expression and prognosis in cutaneous malignant melanoma.","volume":"19","author":"Duncan","year":"2001","journal-title":"J Clin Oncol"},{"key":"R135-1-20210202","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/S0046-8177(00)80003-9","article-title":"Patterns of melastatin mRNA expression in melanocytic tumors.","volume":"31","author":"Deeds","year":"2000","journal-title":"Hum Pathol"},{"key":"R136-1-20210202","first-page":"5012","article-title":". Microphthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma.","volume":"60","author":"Salti","year":"2000","journal-title":"Cancer Res"},{"key":"R137-1-20210202","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10555-005-1577-9","article-title":"Functional and therapeutic significance of Akt deregulation in malignant melanoma.","volume":"24","author":"Robertson","year":"2005","journal-title":"Cancer Metastasis Rev"},{"key":"R138-1-20210202","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1200\/JCO.2005.07.168","article-title":"Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases.","volume":"23","author":"Dai","year":"2005","journal-title":"J Clin Oncol"},{"key":"R139-1-20210202","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/PAS.0b013e31816fd53c","article-title":". Novel role for RGS1 in melanoma progression.","volume":"32","author":"Rangel","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R140-1-20210202","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/cncr.25838","article-title":". Prognostic significance of RUNX3 expression in human melanoma.","volume":"117","author":"Zhang","year":"2011","journal-title":"Cancer"},{"key":"R141-1-20210202","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1479-5876-9-114","article-title":". Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: an analysis of 215 cases from the Malmo Diet and Cancer Study.","volume":"9","author":"Jonsson","year":"2011","journal-title":"J Transl Med"},{"key":"R142-1-20210202","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2407-7-24","article-title":". E2F-1 induces melanoma cell apoptosis via PUMA up-regulation and Bax translocation.","volume":"7","author":"Hao","year":"2007","journal-title":"BMC Cancer"},{"key":"R143-1-20210202","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.onc.1208374","article-title":". PUMA expression is significantly reduced in human cutaneous melanomas.","volume":"24","author":"Karst","year":"2005","journal-title":"Oncogene"},{"key":"R144-1-20210202","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/jid.2011.464","article-title":". Prognostic importance of the mitotic marker phosphohistone h3 in cutaneous nodular melanoma.","volume":"132","author":"Ladstein","year":"2012","journal-title":"J Invest Dermatol"},{"key":"R145-1-20210202","doi-asserted-by":"crossref","first-page":"e47054","DOI":"10.1371\/journal.pone.0047054","article-title":". The prognostic value of BRAF mutation in Colorectal cancer and melanoma: a systematic review and meta-analysis.","volume":"7","author":"Safaee Ardekani","year":"2012","journal-title":"PLoS One"},{"key":"R146-1-20210202","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1245\/s10434-012-2457-5","article-title":". Prognostic value of BRAF (V600) mutations in melanoma patients after resection of metastatic lymphnodes.","volume":"19","author":"Moreau","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"R147-1-20210202","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1002\/cncr.26724","article-title":". NRAS mutation status is an independent prognostic factor in metastatic melanoma.","volume":"118","author":"Jakob","year":"2012","journal-title":"Cancer"},{"key":"R148-1-20210202","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/jid.2012.36","article-title":". AIM1 and LINE-1 epigenetic aberrations in tumor and serum relate to melanoma progression and disease outcome.","volume":"132","author":"Hoshimoto","year":"2012","journal-title":"J Invest Dermatol"},{"key":"R149-1-20210202","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/PAT.0b013e328353a0ff","article-title":". Prognostic significance of MGMT gene promoter methylation in differently treated metastatic melanomas.","volume":"44","author":"Cesinaro","year":"2012","journal-title":"Pathology"},{"key":"R150-1-20210202","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/jnci\/djj103","article-title":". Gene expression profiling of primary cutaneous melanoma and clinical outcome.","volume":"98","author":"Winnepenninckx","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R151-1-20210202","doi-asserted-by":"crossref","first-page":"6939","DOI":"10.1158\/1078-0432.CCR-09-1631","article-title":". Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival.","volume":"15","author":"Conway","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R152-1-20210202","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/sj.onc.1210700","article-title":". High expression of DNA repair pathways is associated with metastasis in melanoma patients.","volume":"27","author":"Kauffmann","year":"2008","journal-title":"Oncogene"},{"key":"R153-1-20210202","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1158\/1078-0432.CCR-10-1521","article-title":". Patterns of expression of DNA repair genes and relapse from melanoma.","volume":"16","author":"Jewell","year":"2010","journal-title":"Clin Cancer Res"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0b013e31828a2ec5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,26]],"date-time":"2024-05-26T09:32:27Z","timestamp":1716715947000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201405000-00001"}},"subtitle":["Update on Diagnostic and Prognostic Biomarkers"],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":150,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0b013e31828a2ec5","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}